264 related articles for article (PubMed ID: 25550809)
21. MicroRNA-202 induces cell cycle arrest and apoptosis in lung cancer cells through targeting cyclin D1.
Jiang J; Huang J; Wang XR; Quan YH
Eur Rev Med Pharmacol Sci; 2016 Jun; 20(11):2278-84. PubMed ID: 27338052
[TBL] [Abstract][Full Text] [Related]
22. Chemotherapy-Regulated microRNA-125-HER2 Pathway as a Novel Therapeutic Target for Trastuzumab-Mediated Cellular Cytotoxicity in Small Cell Lung Cancer.
Yagishita S; Fujita Y; Kitazono S; Ko R; Nakadate Y; Sawada T; Kitamura Y; Shimoyama T; Maeda Y; Takahashi F; Takahashi K; Tamura T; Koizumi F
Mol Cancer Ther; 2015 Jun; 14(6):1414-23. PubMed ID: 25833836
[TBL] [Abstract][Full Text] [Related]
23. miR Profiling Identifies Cyclin-Dependent Kinase 6 Downregulation as a Potential Mechanism of Acquired Cisplatin Resistance in Non-Small-Cell Lung Carcinoma.
Bar J; Gorn-Hondermann I; Moretto P; Perkins TJ; Niknejad N; Stewart DJ; Goss GD; Dimitroulakos J
Clin Lung Cancer; 2015 Nov; 16(6):e121-9. PubMed ID: 25703099
[TBL] [Abstract][Full Text] [Related]
24. [MiR-665 Promotes the Biological Behavior of Small Cell Lung Cancer by Targeting LLGL1].
Liu R; Zhang L; Xu Z; Cui Y
Zhongguo Fei Ai Za Zhi; 2020 Apr; 23(4):223-232. PubMed ID: 32222154
[TBL] [Abstract][Full Text] [Related]
25. Long non-coding RNA TUG1 is involved in cell growth and chemoresistance of small cell lung cancer by regulating LIMK2b via EZH2.
Niu Y; Ma F; Huang W; Fang S; Li M; Wei T; Guo L
Mol Cancer; 2017 Jan; 16(1):5. PubMed ID: 28069000
[TBL] [Abstract][Full Text] [Related]
26. Suppression of HELLS by miR-451a represses mTOR pathway to hinder aggressiveness of SCLC.
Cui J; Wang J; Shen Y; Lin D
Genes Genomics; 2021 Feb; 43(2):105-114. PubMed ID: 33460027
[TBL] [Abstract][Full Text] [Related]
27. microRNA-195 Promotes Small Cell Lung Cancer Cell Apoptosis via Inhibiting Rap2C Protein-Dependent MAPK Signal Transduction.
Tong J; Lu J; Yin Y; Wang Y; Zhang K
Technol Cancer Res Treat; 2020; 19():1533033820977546. PubMed ID: 33302819
[TBL] [Abstract][Full Text] [Related]
28. Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer.
Fang S; Zeng X; Zhu W; Tang R; Chao Y; Guo L
Exp Mol Pathol; 2014 Jun; 96(3):438-44. PubMed ID: 24769353
[TBL] [Abstract][Full Text] [Related]
29. miR-126 inhibits proliferation of small cell lung cancer cells by targeting SLC7A5.
Miko E; Margitai Z; Czimmerer Z; Várkonyi I; Dezso B; Lányi A; Bacsó Z; Scholtz B
FEBS Lett; 2011 Apr; 585(8):1191-6. PubMed ID: 21439283
[TBL] [Abstract][Full Text] [Related]
30. EPHA3 regulates the multidrug resistance of small cell lung cancer via the PI3K/BMX/STAT3 signaling pathway.
Peng J; Wang Q; Liu H; Ye M; Wu X; Guo L
Tumour Biol; 2016 Sep; 37(9):11959-11971. PubMed ID: 27101199
[TBL] [Abstract][Full Text] [Related]
31. LncRNA MCM3AP-AS1 sponges miR-148a to enhance cell invasion and migration in small cell lung cancer.
Luo H; Zhang Y; Qin G; Jiang B; Miao L
BMC Cancer; 2021 Jul; 21(1):820. PubMed ID: 34271873
[TBL] [Abstract][Full Text] [Related]
32. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA signature of small-cell lung cancer after treatment failure: impact on oncogenic targets by miR-30a-3p control.
Tanigawa K; Misono S; Mizuno K; Asai S; Suetsugu T; Uchida A; Kawano M; Inoue H; Seki N
Mol Oncol; 2023 Feb; 17(2):328-343. PubMed ID: 36345848
[TBL] [Abstract][Full Text] [Related]
34. Intensified Beclin-1 Mediated by Low Expression of Mir-30a-5p Promotes Chemoresistance in Human Small Cell Lung Cancer.
Yang X; Bai F; Xu Y; Chen Y; Chen L
Cell Physiol Biochem; 2017; 43(3):1126-1139. PubMed ID: 28977798
[TBL] [Abstract][Full Text] [Related]
35. Downregulation of USP32 inhibits cell proliferation, migration and invasion in human small cell lung cancer.
Hu W; Wei H; Li K; Li P; Lin J; Feng R
Cell Prolif; 2017 Aug; 50(4):. PubMed ID: 28597490
[TBL] [Abstract][Full Text] [Related]
36. MicroRNA-886-3P functions as a tumor suppressor in small cell lung cancer.
Shen J; Zhou W; Bi N; Song YM; Zhang FQ; Zhan QM; Wang LH
Cancer Biol Ther; 2018; 19(12):1185-1192. PubMed ID: 30230945
[TBL] [Abstract][Full Text] [Related]
37. Mir-24-3p downregulation contributes to VP16-DDP resistance in small-cell lung cancer by targeting ATG4A.
Pan B; Chen Y; Song H; Xu Y; Wang R; Chen L
Oncotarget; 2015 Jan; 6(1):317-31. PubMed ID: 25426560
[TBL] [Abstract][Full Text] [Related]
38. The Expression of miR-375 Is Associated with Carcinogenesis in Three Subtypes of Lung Cancer.
Jin Y; Liu Y; Zhang J; Huang W; Jiang H; Hou Y; Xu C; Zhai C; Gao X; Wang S; Wu Y; Zhu H; Lu S
PLoS One; 2015; 10(12):e0144187. PubMed ID: 26642205
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of secretagogin inhibits cell apoptosis and induces chemoresistance in small cell lung cancer under the regulation of miR-494.
Bai Y; Sun Y; Peng J; Liao H; Gao H; Guo Y; Guo L
Oncotarget; 2014 Sep; 5(17):7760-75. PubMed ID: 25226615
[TBL] [Abstract][Full Text] [Related]
40. miR-107 regulates cisplatin chemosensitivity of A549 non small cell lung cancer cell line by targeting cyclin dependent kinase 8.
Zhang Z; Zhang L; Yin ZY; Fan XL; Hu B; Wang LQ; Zhang D
Int J Clin Exp Pathol; 2014; 7(10):7236-41. PubMed ID: 25400821
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
